The present pathological study on the male rats aims to investigate the effects on liver tissue induced by repeated administration of three doses of sustanon for four periods. The experiment was done on the 100 adult male rats randomly divided into five groups 20 rats in each group. The first group is considered as a negative control treated with diet and water only. The second group is considered a positive control treated weekly for 60 days with sesame oil intramuscularly while groups III, IV and V treated with diluted sustanon in 5, 10 and 20 mg/kg body weight intramuscularly weekly for 60 days respectively. Blood was collected in a period 15, 30 and 60 days after treatment for measurements liver function tests ALT (alanine aminotransferase) and AST (aspartate aminotransferas) enzymes. Then the animals were dissected to take samples in a period 15, 30 and 60 days after treatment for histopathological examination, then 5 rats were lefted in each group in the diet and water for 30 days after last treatment for examination the above mentioned parameters. The results revealed the presence of significantly increasing of liver enzyme activation represented by ALT and AST at level P<0.05 compared with control groups. The value of these levels were higher in group V in a day 60 after treatment and its continue to increase even after stopping treatment and remained on diet and water only for 30 days. Pathologically, all treated groups with sustanon revealed gross and histopathological changes in liver tissue, there were enlargement and congestion gross. Histopathologically, the liver sections elucidate cellular swelling, vacuolar degeneration in the cytoplasm of hepatocytes in addition to fatty change and programmed cell death in all groups during a period 15, 30 and 60 days these changes continue even after stopping the treatment for 30 days but portal fibrosis has been observed.It has been concluded from this study that sustanon in concentration 5, 10, 20 mg /kg of body weight in aperiods 15, 30 and 60 have ability to induce hepatotoxic effect on liver of male rat and these effects irreversible and progressive for 30 days after stopping the drug administration. Sciences, Vol. 28, No. 1, 2014 (31-39) 
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Introduction
The phenomenon of abusing Anabolic androgenic steroids (AAS) by many youth and athletes is aserious health phenomenon which increase rapidly in recent years (1, 2) . Anabolic androgenic steroids are group of synthetic compounds related to testosterone structurally (3, 4) androgens play a central role in the biology on medical practice in status as muscle wasting or debilitation (3). The high doses of these anabolic steroids such as metanedienone, stanozolole,oxandrolone and sustanon, in order to abtain and produce arapid and huge increasing in the skeletal muscle mass and to improve there performance during the sport competition (5).
For instance,sustanon (Androgenicum prolongatum) is one of these AAS which has many useful therapeuties usages, it is clinically used to treat cases of osteoporosis, male hypogonadisms and infertility (6) . Inregard sustanon it is characterized by avery unique and distinguish pharmacological structure and properties comparing to other AAS drugs,it is consiste of an oily mixture of four different testosterone ester compound which provide a continuous release of testosterone into the blood serum for duration extent to 3 -4 weeks (7, 8) .
These drugs was giving to race horse and dogs who wish to improve physical performance (1, 8, 9) . Anabolic androgenic steroids suggest could be apossible new risk facter for causing adisease termed toxicant associated steatohepatitis (TASH) (10) . It have ability to give significant increase in muscle mass and strength, these are the main reasons why many body builders prefer to include sustanon dosage in the cycle because it can produce immediate results as a fast acting steroid,Beside this significant, there was many side effect produce from using sustanon.for example since that compound easily converted to estrogen so increase growth of breast tissues, this condition called gynecomastia (11) .
Previous studies also reported many serious adverse effects resulted from abusing these anabolic drugs which induce cardiovascular disorder (particularly enlargement of the left ventricle) which can lead to sudden death, acute hepatitis and jaundice, testicular dysfunction, which lead to infertility, hypertension, behavioral disorders (12) (13) (14) (15) (16) (17) (18) (19) (20) .
By reviewing the literature it was observed that hepatic histological changes induced by sustanon have been limited studies so, this study conducted to documented and reported the histological and biochemical alteration in liver enzymes of graded doses of sustanon in different peroids on hepatic tissue.
Materials and methods
Ethical approval
The study was approved by Section of Animal Ethics Committee in the College of Veterinary Medicine, University of Mosul.
Male albino rats were obtained as three months old from laboratory animal house of veterinary medical college, body weight 250-350 gm. Animals had free access to laboratory chaow and tap water. They were maintained on a 12:12 hour light -dark cycle and housed in an animal room where the temperature (22-26°C) was controlled.
100 male rats were randomly divided into 5 groups of 20 rats each. Group I received the regular rate diet and maintained as negative control group, group II were intramuscular (IM) injected with sesame oil (Which used to dilute sustanon for injection), group III, IV, and V treated with IM injection of sustanon (Androgenicum prolongatum) in concenteration 250mg/ml (obtained from organon Oss Holand company) about (5, 10 and 20 mg/kg of body weight), respectively for 60 days one dose weekly.five rats from each group remained for 30 days (30 days after stopping of treatment additives on normal diet and water only).
Blood samples were taken from eye vein, after over neight fast for 12 hours and biochemical analysis performed in fresh heparin treated serum.
Serum were collect at 15, 30 and 60 days after treatment then at 30 days after stopping the administration of sustanon and only dieting on normal diet and water. Serum was obtained by centrifugation at 3000 RPM for 15 minutes and stored at -4°C for enzyme assays.
ALT, AST were analyzed by using commercial kits from Biolabo French Company.
Sustanon obtained from organon Oss Holand company (250 mg/ml) and the volume used is 5 ml. and we use sesame oil from Bailasan company/mosul/Iraq.
Procedures
For light microscopy livers of the animal from different groups were examined for gross fixed then perfused in 10% neutral buffered formaline for 48-72 hours. The specimens were dehydrated in ascending grades of alcohol, clearing in xylene and embedded in paraffin wax, 4-6 Microne thickness sections were obtained and stained with Harris haematoxylin and eosin (H&E) for microscopic examination (21) .
Statistical Analysis
We use SPSS program Sixteen edition we use analysis of Varians ANOVA (one way analysis) and Duncan's test to test the significant differences between the groups at level P<0.05 (22) .
Results
Results of the blood serum biochemical analysis are listed in table 1 
Pathological changes Macroscopic Changes
Rats liver treated with 5 mg/kg/B.W. of sustanon showed swelling association with pin point hemorrhage in a period 15, 30 and 60 days of IM injection. This lesion continue and more evidence at 30 days after stopping treatment as compared with control group moreover in a dose 20 mg/kg B.wt. Severe enlargement with fatty in consistency associated with petechial hemorrhage on ventral surface of hepatic tissue was observed (Figure 3) , at 15 and 30 days and more evidence at 60 days post treated, but after leaving animal without treatment with sustanon for 30 days it showed granules in consistency associated with sever congestion (Figure 4 ), as compared with control groups. 
Microscopic changes
Histopathological section of rats liver showed no histological lesions in control groups, while in group treated with sustanon in a dose 5 mg/kg Bwt after 15 days illustrated congestion of blood vessels (artery and vein) in In animal left without treatment with A. p. for 30 days and feeding on normal diet and water only liver showed portal fibrosis (collagen proliferation, newly capillaries and newly caniliculi), bile pigment deposition in addition to loss of the normal arrangement of hepatic cord and appoptic hepatocytes (Figuers 9-11 ). 
Discussion
The result of this study showed that IM injection of sustanon at 5, 10, 20 mg/Kg BW for 15, 30 and 60 days induce hepatotoxicity in male rats of groups III, IV and V as verified by biochemical and histological finding, and marked elevation in level of ALT and AST in blood serum of male in group III, IV, V as compared with control groups and these elevation continued after stopping treatment for 30 days, suggestion that these changes reflected the occurrence of liver injury. The present results support the previous study of (23) who reported that administration of sustanon in a dose 5 mg/kg b.w. subcutaneously for 10 weeks cause increase level of ALT as compared with control group. The elevation of ALT and AST in blood serum with increasing the dose means damages of hepatocytes was take place through the damaging of mitochondria, which lead to leakage this enzyme outside of hepatocytes and reach to blood ALT is more specific for liver injury than AST (24) . Using anabolic steroid randomly for long time can induce hepatotoxicity and morphological alterations of the liver cells.
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On the other hand, AST activity was increased in animal treated with sustanon, it may indicate the presence of muscle damage as well as hepatocytes because these enzyme is specific for muscle so it means that damage of muscle also take place (25) .
This study was not in agreement with other studies shows that serum parameters commonly evaluated in athletes to test hepatic function are not substantially modified by administration of the anabolic steroids employed (26) . The uses of anabolic androgenic steroids particularly sustanon cause alteration in liver function due to alteration in morphological and histological structure of hepatocytes.
The pathological changes revealed hypertrophy, congestion in central vein and sinusoid (particularly in 20 mg/kg Bwt for 30 to 60 days) indication for chronic venous congestion takeplace, also fatty changes in consistency was observed, and these changes reflect to injury of liver cell occurrence due to toxic hypoxia producing from different doses of sustanon like other anabolic steroid (16) . Congestion and hemorrhage take place due to increase hydrostatic pressure in blood cause vessels accumulation of red blood cell in the lumen of blood vessels, which allow blood cells to diapedsis and leakage out the blood vessels to cause bleeding. Moreover, sustanon may have ability to cause lipid peroxidation via reactive oxygen species which lead to fatty changes in addition to hypoxia.
Histopathological lesions also observed in this study started in 5 mg/kg Bwt, and reach to 20 mg/kg B.wt. in 15, 30, 60 days which continues after stopping treatment for 30 days, this means that sustanon have ability to induce progress liver cell injury because its considered as a first organ responsible for metabolism of sustanon compound. So, this injury induced by accumulation of toxic metabolite (Xenobiotic) from sustanon metabolism that includes 17, α-19-Nortesterone, 17-α-testosterone (27) .
On the other hand, figures showed cell swelling, sinusoid dilation and congestion in addition to centrolobular necrosis, these lesions occurs due to that sustanon like other anabolic androgenic steroid have ability to cause injury of hepatocytes through the effect on mitochondria particularly mitochondrial membrane and inhibit mitochondrial respiration which lead to swelling of mitochondria and cause leakage of ALT and AST (28) .
An interesting finding in this study was a presence of programmed cell death in hepatocytes, like other anabolic androgenic steroid for example blodenone undecyleante (29) they illustrated that this drug have ability to cause programmed cell death by using immunohistochemistry through increasing in a protein P 53 which responsible for programmed cell death (so this observation need more studying in future). Also, our study suggested that sustanon have ability to cause programmed cell death through the ability to damage cell DNA and mitochondria.
Moreover, this study showed presence of fibrosis in portal area particularly in animal lefted for 30 days after stopping the treatment, this means that liver go to healing the damaged cells by fibrosis in portal area not regeneration of other hepatocytes because the damage is powerful and strong and may need more than 30 days for regenerations because sustanon remain in tissue for 4 weeks after stopping administration (29) .
